FDA DEVICE FACTS
Powder Free Nitrile Examination Glove, Non-sterile, Tested for Use with 46 Chemotherapy Drugs, the Opioid Fentanyl citrate, simulated Gastric Acid, Fentanyl in Gastric Acid, the tranquilizer Xylazine, and Xylazine in Fentanyl citrate (Blue)
Ksg Medicare Sdn. Bhd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
A Nitrile powder free examination glove is a disposable device intended for medical purposes, worn on the examiner’s hand or finger to prevent contamination between examiner and patient. This specialty glove has also been tested for use with 46 Chemotherapy drugs, the Opioid Fentanyl citrate, simulated Gastric Acid, Fentanyl in Gastric Acid, the tranquilizer Xylazine, and Xylazine in Fentany] citrate. Gloves tested for Permeation Breakthrough Resistance in accordance with ASTM D6978: 46 Chemotherapy Drugs; the Opioid Fentanyl citrate, simulated Gastric Acid, Fentanyl in Gastric Acid, the tranquilizer Xylazine, and Xylazine in Fentanyl citrate No No CHEMOTHERAPY DRUG __|Breakthrough||J|_ CHEMOTHERAPY DRUG Breakthrough up to __ _ up to: | Gemcitabine HCI, 38 mg/ml >240 min. Azacytidine (Vidaza), 25 mq/ml >240 min. idarubicin HCl, 1 mg/ml 5240 min. Bendamustine HCI, 5 mg/ml >240 min. ifosfamide (IFEX), 50 mg/ml >240 min. Bleomycin Sulfate, 15 mq/ml >240 min. irinotecan HCl, 20 mg/ml 5240 min. Bortezomib (Velcade), 1 mg/ml 2240 min. Mechlorethamine HCl, 1 mg/ml >240 min. Busulfan, 6 mg/ml >240 min. Melphalan HCl, 5 mg/ml >240 min. Carboplatin, 10 mg/ml >240 eta Methotrexate, 25 mg/ml >240 min. Carfilzomib, 2 mg/ml >240 min. Mitomycin C, 0.5 mg/ml >240 min. Carmustine, 3.3 mg/ml 13.6 — Mitoxantrone HCl, 2 mg/ml >240 min. Cetuximab (Erbitux), 2 mg/ml >240 min. Oxaliplatin, 5 mg/ml >240 min. Cisplatin; 1 ma/ml >240 min. Paclitaxel (Taxol),6 mg/ml >240 min. Cladribine, 1 mg/ml >240 min. Pemetrexed, 25 mg/ml >240 min. Cyclophosphamide, 20 mq/ml >240 min. Raltitrexed, 0.5 mg/ml 3240 min. Cyclosporin A, 100 mg/ml >240 mn Retrovir (Zidovudine),10mg/ml >240 min. Cytarabine HCI (Cytosine) >240 min. Rituximab, 10 mg/ml >240 min. Cytovene (Ganciclovir) 10 mg/ml >240 min. ThioTEPA, 10 mg/ml 24.3 min Dacarbazine (DTIC), 10 mg/ml >240 min. Topotecan HCl, 1 mgm 5240 min Daunorubicin HCI, 5 mg/ml >240 min. THEEHOX (Arsenic Trioxide) — Decitabine, 5 mg/ml >240 min. 4 mg/ml , >240 min. Docetaxel, 10 mg/ml >240 min. Vinblastine Sulfate, 1 mg/ml >240 min. Doxorubicin HCl, 2 mg/ml >240 min. Vincristine Sulfate (Oncovin) , Epirubicin HCI, 2 mq/ml >240 min. 4 mg/ml >240 min. Etoposide, 20 mg/ml >240 min. Vinorelbine, 10 mg/ml >240 min. ElugarabineiPhosphate.zo:rqiml|| | =240'min: Zoledronic Acid, 0.8 mg/ml 3240 min. 5-Fluorouracil, 50 mg/ml >240 min. Caution: Carmustine and ThioTepa have extremely low minimal breakthrough times of 13.6 minutes and 24.3 minutes respectively. Warning: Do not use with Carmustine or ThioTepa Opioid Drug and Concentration Tested No Breakthrough up to: Fentanyl citrate, (injectable) 100 mg/2ml >240 minutes Gastric Acid (simulated), 0.2% NaCl in 0.7% HCL >240 minutes Fentanyl in Gastric Acid 50/50 mix >240 minutes Tranquilizer Xylazine Drug and Concentration Tested No Breakthrough up to: Xylazine HCL, 100 mg/ml >240 minutes Xylazine HCL, 100mg/ml in Fentanyl citrate >240 minutes
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。